Skip to main content
Clinical Trials/DRKS00022882
DRKS00022882
Completed
Not Applicable

The impact of treatment expectation on the effectiveness and tolerability of prophylaxis in migraine patients

Klinische NeurowissenschaftenUniversitätsklinikum EssenKlinik für Neurologie0 sites134 target enrollmentDecember 8, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G43.0
Sponsor
Klinische NeurowissenschaftenUniversitätsklinikum EssenKlinik für Neurologie
Enrollment
134
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2020
End Date
January 31, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinische NeurowissenschaftenUniversitätsklinikum EssenKlinik für Neurologie

Eligibility Criteria

Inclusion Criteria

  • Patients with episodic or chronic migraine starting a new medical prophylaxis comprising amitriptyline, beta blockers, topiramate, valproic acid, magnesium, flunarizine or onabotulinumtoxinA (new prophylaxis or add on)

Exclusion Criteria

  • pregnancy or breast\-feeding
  • missing language skills

Outcomes

Primary Outcomes

Not specified

Similar Trials